Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WB007 in glaucoma or ocular hypertension
NCT04149899Phase 2Completed
- Sponsor
- Bausch + Lomb
- Start
- Nov 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WB007 in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Bausch + Lomb. Started Nov 2019; status: completed.
02
Drugs
WB007
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT04149899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04149899.